Large-scale semaglutide trials (SUSTAIN and STEP studies) did not identify insomnia as a primary side effect
"These medications are treating obesity by potentially regulating, or resetting or decreasing, that defended mass set point." People do tend to regain weight after they stop taking these drugs
An electrolyte supplement prevents the cramping, dizziness, and fatigue that electrolyte imbalance causes
Because retatrutide is not a licensed medicine in the UK, the MHRA advises against its use outside of formal clinical trials or a named-patient pathway authorised by a responsible clinician
Since Vitamin D is fat-soluble, and your diet may change to include less fat while on a weight loss program, your levels might dip
Jacob D, Deborde C, Lefebvre M, Maucourt M, Moing A